BiosimilarsMeSH concept

https://www.insee.fr/fr/statistiques/8186061?sommaire=8186084
2024
France
journal article
Assessment
disease models, animal
Physical Examination
france
motivation
GDC Therapeutic Agent Terminology
hospital, nos
insurance, health
Shared
Prescribing Domain
biosimilar pharmaceuticals
drug evaluation
Medication
Biosimilar
tularemia
Health Insurance
Assessment
experimental drug, nos
Share
CHFR Gene
Biosimilars
Evaluation
tularemia, nos
hospitals

---
https://www.cochrane.org/fr/CD013539/CENTRALED_les-anticorps-monoclonaux-biosimilaires-sont-ils-aussi-efficaces-que-le-medicament-dorigine-pour-le
2024
United Kingdom
review of literature
french abstract
cancer
neoplasms
drug, nos
drug therapy
antibodies, monoclonal
biosimilar pharmaceuticals
Biosimilars
neoplasm, malignant
monoclonal antibody

---
https://www.bag.admin.ch/bag/fr/home/das-bag/aktuell/news/news-22-06-2023.html
2023
Switzerland
scientific and technical information
biosimilar pharmaceuticals
Biosimilars

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2022-utilisation-biosimilaires-anti-tnf-alpha
2022
France
Biosimilars
anti-TNF
France
France
France
biosimilar pharmaceuticals
tumor necrosis factor alpha
france
french
France
tumor necrosis factor-alpha

---
https://www.cosprc.ca/fr/enonce-de-position-de-la-societe-canadienne-dophtalmologie-sco-sur-les-biosimilaires/
2022
Canada
guideline
ophthalmology
Ophthalmology
Ophthalmology
ophthalmologist
Biosimilars
biosimilar pharmaceuticals

---
https://dumas.ccsd.cnrs.fr/dumas-02964445
2020
France
dissertations, academic
oceans and seas
Biosimilars
adoption
hospitals
adoption, nos
biosimilar pharmaceuticals
central
hospital, nos
drug, nos

---
https://pgtmsite.files.wordpress.com/2024/01/biosimilaires-en-oncologie_version-20181023-colloque-gestion-1.pdf
2018
Canada
drug information
Biosimilar
Biosimilars
biosimilar pharmaceuticals
Proficiency Testing Challenge
Challenge

---
https://pgtmsite.files.wordpress.com/2024/01/biosimilaires_presentation_ppt_pgtm_maj_juin2108-1.pdf
2018
Canada
drug information
Biosimilar
insight, nos
knowledge
US State
State
Biosimilars
biosimilar pharmaceuticals
Status
State Ownership
health planning guidelines
acquaintance

---
https://pgtmsite.files.wordpress.com/2024/01/presentation-biosimilaires_pgtm_grum_avr2017_20170426.pdf
2017
Canada
drug information
Deoxyuridine
acquaintance
Biosimilars
knowledge
State Ownership
Biosimilar
US State
insight, nos
Daur Chinese
State
Conference
Status
Due
biosimilar pharmaceuticals
Device-In-Use Domain
health planning guidelines

---
https://pgtmsite.files.wordpress.com/2024/01/biosimilaires_eva_pgtm_version-finale-10avr2017.pdf
2017
Canada
drug information
biosimilar pharmaceuticals
Status
Biosimilars
health planning guidelines
Biosimilar
US State
acquaintance
State
State Ownership
insight, nos
knowledge

---
https://pgtmsite.files.wordpress.com/2024/01/biosilaires_article_points_vue_pgtm_j_pharm_clin_publie_201703-1.pdf
2017
Canada
drug information
Pharmacologic Management
Biosimilars
KAT5 wt Allele
vision, ocular
TIP Regimen
Treatment
Chronic Villitis
Biosimilar
insurance, pharmaceutical services
quebec
therapeutic uses
patient care planning
Scheduled
Tip
academic medical centers
Schedule
Study Coordinating Center
Point Name
biosimilar pharmaceuticals
Therapeutic
disease management
central
Use
Sight
drug utilization
drug, nos
hospital, nos
drug therapy
TIP GCT Study Identifier
Program
Point

---
https://tel.archives-ouvertes.fr/tel-01715097
2017
false
false
false
France
French
dissertations, academic
biosimilar pharmaceuticals
Polyarthritis
patient care management
arthritis, rheumatoid
Rheumatoid arthritis
drug, nos
Biosimilars

---
http://www.snfge.org/download/file/fid/2784
2017
false
false
false
France
French
drug information
Biosimilars
Infliximab
biosimilar pharmaceuticals

---
https://pgtmsite.files.wordpress.com/2024/01/article_bisosimilaires_medactuel_oct2017_site-web.pdf
2017
Canada
drug information
Hub Device
central
Centi
Center
hospitals
Biosimilars
biosimilar pharmaceuticals
Biosimilar
hospital, nos

---